Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teradyne, Inc. (TER) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Teradyne, Inc.Trade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Teradyne, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Teradyne, Inc. trades at $354.36 (market cap $59.45B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Teradyne, Inc. is far larger — about 33× Vir Biotechnology Inc. Common Stock's market cap, and Teradyne, Inc. pays a 0.14% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teradyne, Inc. for 37 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TERVIR
Market Cap
$59.45B$1.80B
Volume
2,735,5411,782,836
Sector
TechnologyHealth
52-Week High
$483.84$11.78
52-Week Low
$138.09$5.12
Typical Hold Time
37 Days0 Days
Enterprise Value
$59.20B$1.36B
Dividend Yield
0.14%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Teradyne, Inc.

Teradyne (TER) trades at $359.44, down 6.36% over 24 hours, reflecting recent bearish technical signals. The stock shows strong fundamentals with a 25.77% net income margin and consistent earnings beats in recent quarters. Recent news highlights expansion in AI-driven test equipment, including the Magnum E2 and Iris 100 platforms, targeting growth in semiconductor and data center markets. Analyst consensus remains bullish with a $461.50 price target, though technical indicators suggest near-term caution.

Outlook is positive due to robust profitability and AI-related demand, but risks include competitive pressures and market volatility. The stock offers growth potential if execution aligns with analyst expectations, though investors should monitor earnings consistency and industry trends.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TER
70% Buy30% Sell
Avg holding period · 37 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Read more on TER →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →